Biohaven Pharma forms wholly owned AsiaPacific subsidiary BioShin

Biohaven Pharma forms wholly owned Asia─Pacific subsidiary, BioShin

12:06 EST 30 Nov 2018 | PharmaBiz

Biohaven Pharmaceutical Holding Company Ltd has advanced the formation of a wholly owned subsidiary, BioShin, a Shanghai based limited liability company, to develop and commercialize its late─stage

Original Article: Biohaven Pharma forms wholly owned Asia─Pacific subsidiary, BioShin

More From BioPortfolio on "Biohaven Pharma forms wholly owned Asia─Pacific subsidiary, BioShin"